Pre-Filled Syringes: World Market Outlook 2011-2021Visiongain
June 21, 2011
197 Pages - SKU: VSG6468316
5.3 Byetta/Exenatide LAR: Non-Insulin Revolutionary Injectable
Eli Lilly/Amylin's GLP-1 agonist anti-diabetic drug Byetta (exenatide) is available for subcutaneous injection as a solution in a glass cartridge that has been assembled in a pen-injector format. Byetta pre-filled pen is available as either 5ìg or 10ìg exenatide per dose. Byetta enjoyed marked success in 2007, where its sales grew by 51% over the previous year, reaching a total of $0.650bn. For the year extending through the second quarter of 2008, Byetta generated sales of $0.669bn, with a growth of 30%. It has continued to enjoy high growth and generated sales revenues of $0.797 billion for the whole of 2009, which was a growth of 6% from the previous year. In 2010, the worldwide sales of Byetta reached $0.710bn and visiongain predicts sales to reach $1.00bn by 2015 and $1.28 billion by 2021 (Tables 5.14-5.15 and Figure 5.7). With the withdrawal of rosiglitazone from EU markets, Byetta will perform well until pipeline drugs enter the market, improving diabetes treatment. Sales will rise with the entry of Byetta/Exenatide LAR to the market.
Alshifa Medical Syringes Manufacturing Company
B. Braun Medical
Battelle Medical Device Solutions
BD Healthcare Consulting & Services (BDHCS)
BD Pharmaceutical Systems
Becton, Dickinson and Company
Bioject Medical Technologies
Boston Scientific Corp.
C. R. Bard.
Cambridge Antibody Technology (now a part of AstraZeneca)
Catalent Pharma Solutions
Centers for Disease Control and Prevention (CDC) [US]
Centocor Ortho Biotech
Chugai Pharmaceutical (a subsidiary of Roche Holding AG.)
E. R. Squibb & Sons
European Medicines Agency (EMEA/EMA)
European Society for Medical Oncology
Food and Drug Administration (FDA) [US]
GeneScience Pharmaceutical Co.
Hindustan Syringes and Medical Devices
Hi-Tech Medical Products
Human Genome Sciences
Hyaluron Contract Manufacturing
International Medication Systems
Johnson & Johnson
LG Life Sciences
Merck & Co.
Merit Medical Systems
MG Sterile Products
Ministry for Health, Labor and Welfare [Japan]
National Health Service (NHS) [UK]
Occupational Safety and Health Administration (OSHA) [US]
Pharmaceutical Research and Manufacturers of America (PhRMA)
PRC State Food and Drug Administration [China]
Revolutions Medical Corporation
Royal College of Nursing (RCN) [UK]
Sanofi (previously sanofi-aventis)
Shanghai Celgen Bio-Pharmaceutical Co.
Smiths Medical International
Specialised Health Products International
State Food and Drug Administration [China]
Takeda Pharmaceutical Company
Terumo Medical Corporation
Teva Pharmaceutical Industries
The Research Foundation for Microbial Diseases of Osaka University (BIKEN)
Tonghua Dongbao Pharmaceutical Co.
Unilife Medical Solutions
Vetter Pharma International
Vita Needle Company
West Pharmaceutical Services
World Health Organization (WHO)
Wuxi Yushou Medical Appliances Co.
Wyeth (now part of Pfizer)
More Drug Delivery reports by Visiongain
Drug Delivery Technologies: Commercial Prospects 2012-2022 by Visiongain
How to find industry trends and revenue prospects there What does the future hold for drug delivery technologies? Visiongain's report shows you potential ...
World Diabetes Drug Market 2011-2021 by VisiongainSee all reports like this >>
Where will revenue growth occur in the diabetes treatment market? Our new report shows you the potential that drug market offers from 2011 to 2021, ...
We can help you find what you need. Call us or write us:
Need help in your search?
Drug Delivery Reports
- Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017
- North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
- Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017
- Injectable Drug Delivery to 2018
- European Markets for Diabetes Monitoring, Treatment and Drug Delivery